Pharmacovigilance inspections: what HPRA expects

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

Checking & Corrective Action
Annual Product Review (APR) Product Quality Review (PQR)
Chapter 7: Key Process Areas for Level 2: Repeatable - Arvind Kabir Yateesh.
Overview Lesson 10,11 - Software Quality Assurance
Office of Inspector General (OIG) Internal Audit
Quality Assurance/Quality Control Policy
Network security policy: best practices
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
Photocopies Occasionally need uncontrolled copies
GIQAR Annual Congress 25 – 26 th May Pv QA: Quality Assurance for Pharmacovigilance Allison Jack Manager, R&D Oversight – GCP/PV, Pfizer Ltd BARQA.
The Key Process Areas for Level 2: Repeatable Ralph Covington David Wang.
Introduction to Software Quality Assurance (SQA)
Collaborating with the Quality Code Christopher J Cox Head of Collaborative Partnerships, Nottingham Trent University.
Ship Recycling Facility Management System IMO Guideline A.962
Occupational Health and Safety
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Verification: Quality Assurance in Assessment Verification is the main quality assurance process associated with assessment systems and practice - whether.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
European Enforcement of Pharmacovigilance and Inspection Trends Is compliance possible within the EU? June 7, 2007 Dr. M.C. Koster CEO Vigilex Group.
1 Thank you for visiting our site and welcome to the “Introduction to ISO 22000” Presentation that you requested. For more information.
Guide - Recordkeeping for business activities carried out by contractors Natalie Dewson Senior Advisor Government Recordkeeping Programme Archives New.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
1 The Future Role of the Food and Veterinary Office M.C. Gaynor, Director, FVO EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate.
CBER Common Problems on Source Plasma Inspections Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
© Michael Crosby and Charles Sacker, 2001 Systematic Software Reviews Software reviews are a “quality improvement process for written material”.
Office of Human Research Protection Georgia Health Sciences University.
PharmacoVigilance: Development of PhV systems and processes.
Laboratory equipment Dr. W. Huisman Cairo, November 21th 2012.
Internal Audit Section. Authorized in Section , Florida Statutes Section , Florida Statutes (F.S.), authorizes the Inspector General to review.
PharmacoVigilance: Development of PhV systems and processes VICH Workshop, Dar Es Salaam, Tanzania, 24 June 2015.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.
Roles, responsabilities and outcomes of conduction pharmacovigilance inspections in EU Directorate of Risk Management of Medicines National Authority of.
Authority Requirements Margit Markus Tallinn, 7 May 2009.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Welcome. Contents: 1.Organization’s Policies & Procedure 2.Internal Controls 3.Manager’s Financial Role 4.Procurement Process 5.Monthly Financial Report.
Responsibilities of Test Facility Management, Study Director, Principal Investigator and Study Personnel G. Jacobs Belgian GLP Monitorate Zagreb, 17 December.
© Crown copyright 2007 Safeguarding public health Common Inspection Findings May 2008.
Responsibilities of Sponsor, Investigator and Monitor
Auditors’ Dilemma – reporting requirements on Internal Financial Controls under the Companies Act 2013 and Clause 49 of the Listing agreement V. Venkataramanan.
A LOOK AT AMENDMENTS TO ISO/IEC (1999) Presented at NCSLI Conference Washington DC August 11, 2005 by Roxanne Robinson.
Briefing on MHRA routine inspection of non-commercial clinical trials

Post MHRA Inspection What next?
Governing Body QAPI 2013 Update for ASC
Software Quality Control and Quality Assurance: Introduction
Periodic Safety Update Reports (PSUR)
Responsibilities of Sponsor, Investigator and Monitor
Documentation control
CHANGE CONTROL.
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
Flooding Walkdown Guidance
Temporary Works Co-ordination
TAIEX, Istanbul, April 19th, 2011
Setting up an Internal Audit Program
Internal control - the IA perspective
BACKGROUND 1987 Joint MSC/MEPC working group on:
RECORDS AND INFORMATION
Module 2 Key Principles of the Peer Review Programme
Software Quality Assurance
Operationalizing Export Certification and Regionalization Programmes
How to conduct Effective Stage-1 Audit
Pharmacovigilance updates
Stewardship in biotechnology
What is an Internal Audit
DSC Contract Management Committee Meeting
Operational Risk Management
Contingency Planning for Accidental Surface Water Pollution​ GROUP HSE RULE (CR-GR-HSE-705) EXECUTIVE SUMMARY This rule sets specific requirements to be.
SADC PPP Network PPPs in SADC
Presentation transcript:

Pharmacovigilance inspections: what HPRA expects Michael McDonald, PhD HPRA Veterinary Medicines Information Day 13 June 2018, Hilton Hotel Dublin Airport, Dublin.

Purpose of inspections Monitor compliance of MAHs with their PhV obligations Verify MAHs have a PhV system in place to assume responsibility for VMPs on the market so that appropriate action may be taken by the MAH when necessary Verify MAHs have a QPPV at their disposal, who is responsible for the establishment and maintenance of the PhV system Verify MAHs have a deputy QPPV available to them and that back-up procedures apply in case of absence of QPPV Ensure corrective and preventative action is taken for any non compliances identified 16/05/2019

The HPRA inspection programme Conducting inspections of veterinary MAHs since 2009 Eleven veterinary PhV inspections conducted to date National inspection programme reviewed and developed annually Coordination with European network for centrally authorised products Inspections may be routine or targeted Routine inspections Targeted inspections Part of ongoing monitoring programme Specific issues are identified that indicate that a PhV system may be non-compliant or there is potential for increased risk of non-compliance 16/05/2019

MAHs may be prioritised based on factors such as: Routine inspections MAHs may be prioritised based on factors such as: Number of MAs held Type(s) of products authorised Subcontracted PhV responsibilities Significant organisational changes PhV compliance profile 16/05/2019

Conduct of inspections Typically, two to three days in duration Inspection team consists of inspector(s) and one assessor Key components examined: Organisation inc. defined roles and responsibililities for PhV The QPPV and deputy The Detailed Description of the Pharmacovigilance System The quality management system Adverse event case processing and reporting Periodic Safety Update Report preparation and submission Signal management inc. safety variations Contracts and agreements with third parties Examined through combination of document review and interviews 16/05/2019

Conduct of inspections Deficiencies categorised according to EU agreed definitions, as: Critical Major Minor Findings discussed with MAH throughout inspection, in so far as possible Confidential inspection report prepared and issued to MAH MAH response may request correction of any factual errors and should include proposed corrective and preventative actions 16/05/2019

Vet PhV inspection findings 2009-2018 Examples Incomplete or late training Written procedures for key PhV activities missing or not well defined Late submission of PSURs or SAEs Failure to submit follow-up information on AEs or incorrect classification of AEs Top three areas 16/05/2019

Other common findings and how they can be avoided Contractual agreements unclear with respect to PhV roles and responsibililties 24 hour access to QPPV PhV audits – internal and external Failure to define processes to ensure collection of AEs from all potential sources Access to a veterinarian, if required 16/05/2019

Key areas examined during inspection QPPV Backup arrangements are clearly detailed Adequate documentation is maintained regarding QPPV responsibilities and oversight DDPS DDPS regularly reviewed and maintained Variations submitted to competent authorities as necessary 16/05/2019

Key areas examined during inspection PSURs and AEs SOPs are in place, adequately cover all activities, and are reviewed and updated as necessary Accurate and complete records from time of case creation to close-out! Timely reporting to HPRA Contracts and agreements Signed and dated contracts/agreements in place with all relevant third parties Roles and responsibilities regarding PhV clearly defined 16/05/2019

Key areas examined during inspection Signal detection and literature searches Written procedures in place, with responsibilities and timelines clearly defined Appropriate methodology, use of data sources and periodicity Safety variations managed in a timely manner Product quality complaints Interface between Quality Assurance and PhV Product quality complaint and AE logs review and reconciliation 16/05/2019

Key areas examined during inspection Written procedures Written procedures, defining processes for all relevant PhV activities Periodic review, with subsequent updates where necessary Training Ensure all relevant personnel have received at least basic PhV training and that the collection of AEs is assured Training records complete and up-to-date 16/05/2019

Queries? For queries relating to the HPRA’s veterinary PhV inspection programme contact compliance@hpra.ie For queries regarding specific PhV obligations for veterinary MAHs and the underpinning standards contact vetsafety@hpra.ie 16/05/2019

Thank you